PURPOSE: Several reports indicate a complexity in glycosyltransferase activities which lead to several tumor associated carbohydrate structures in gastric carcinoma. The present study was aimed to identify the carbohydrate associated transferases which exhibit the most marked and consistent change of activity in gastric tumorigenesis. METHODS: We examined the levels of fucosyl, beta-galactosyl-, beta-N-acetylgalactosaminyl, sialyl- and glycan:sulfotransferase activities, which generate the outer ends of oligosaccharide chains in tumorous and adjacent normal gastric tissues of the same patient in ten gastric carcinoma cases by using well defined specific synthetic acceptors utilized in our several earlier published studies as referenced in the text (e.g. Chandrasekaran et al. in J Biol Chem 279:10032-10041, 2004; Biochemistry 44:15619-15635, 2005; Carbohydr Res 341:983-994, 2006). RESULTS: Among glycosyltransferases only alpha1,2-fucosyltransferase (FT) was unique in showing a remarkable 40-90% decrease of activity in seven cases. Uniquely several fold elevation of Gal3Sulfo-T(2) (1.9 --> 156.7 fold) and Gal3Sulfo-T(4) (2.4 --> 149.0 fold) activities in all ten cases and moderate elevation of GlcNAc6Sulfo-T (1.3 --> 37.5 fold) activities in nine cases were identified. Poorly differentiated Signet ring cell carcinoma expresses mainly Gal3Sulfo-T(2) activity whereas poorly differentiated adenocarcinoma express predominantly Gal3Sulfo-T(4) activity and also GlcNAc6Sulfo-T activity. But, very low level of these sulfotransferase activities were identified in moderately differentiated gastric carcinomas as well as non-epithelial gastric stromal sarcoma. CONCLUSION: Up regulation of glycan:sulfotransferase activities and down regulation of alpha1,2-fucosyltransferase activity are apparently associated with human gastric tumorigenesis.
PURPOSE: Several reports indicate a complexity in glycosyltransferase activities which lead to several tumor associated carbohydrate structures in gastric carcinoma. The present study was aimed to identify the carbohydrate associated transferases which exhibit the most marked and consistent change of activity in gastric tumorigenesis. METHODS: We examined the levels of fucosyl, beta-galactosyl-, beta-N-acetylgalactosaminyl, sialyl- and glycan:sulfotransferase activities, which generate the outer ends of oligosaccharide chains in tumorous and adjacent normal gastric tissues of the same patient in ten gastric carcinoma cases by using well defined specific synthetic acceptors utilized in our several earlier published studies as referenced in the text (e.g. Chandrasekaran et al. in J Biol Chem 279:10032-10041, 2004; Biochemistry 44:15619-15635, 2005; Carbohydr Res 341:983-994, 2006). RESULTS: Among glycosyltransferases only alpha1,2-fucosyltransferase (FT) was unique in showing a remarkable 40-90% decrease of activity in seven cases. Uniquely several fold elevation of Gal3Sulfo-T(2) (1.9 --> 156.7 fold) and Gal3Sulfo-T(4) (2.4 --> 149.0 fold) activities in all ten cases and moderate elevation of GlcNAc6Sulfo-T (1.3 --> 37.5 fold) activities in nine cases were identified. Poorly differentiated Signet ring cell carcinoma expresses mainly Gal3Sulfo-T(2) activity whereas poorly differentiated adenocarcinoma express predominantly Gal3Sulfo-T(4) activity and also GlcNAc6Sulfo-T activity. But, very low level of these sulfotransferase activities were identified in moderately differentiated gastric carcinomas as well as non-epithelial gastric stromal sarcoma. CONCLUSION: Up regulation of glycan:sulfotransferase activities and down regulation of alpha1,2-fucosyltransferase activity are apparently associated with human gastric tumorigenesis.
Authors: F Carvalho; L David; J P Aubert; A López-Ferrer; C De Bolós; C A Reis; F Gärtner; A Peixoto; P Alves; M Sobrinho-Simões Journal: Virchows Arch Date: 1999-11 Impact factor: 4.064
Authors: H Lahm; S André; A Hoeflich; J R Fischer; B Sordat; H Kaltner; E Wolf; H J Gabius Journal: J Cancer Res Clin Oncol Date: 2001 Impact factor: 4.553
Authors: Y Hippo; M Yashiro; M Ishii; H Taniguchi; S Tsutsumi; K Hirakawa; T Kodama; H Aburatani Journal: Cancer Res Date: 2001-02-01 Impact factor: 12.701
Authors: E V Chandrasekaran; Jun Xue; Jie Xia; Robert D Locke; Shilpa A Patil; Sriram Neelamegham; Khushi L Matta Journal: Biochemistry Date: 2011-10-13 Impact factor: 3.162
Authors: Shilpa A Patil; E V Chandrasekaran; Khushi L Matta; Abhirath Parikh; Emmanuel S Tzanakakis; Sriram Neelamegham Journal: Anal Biochem Date: 2012-03-23 Impact factor: 3.365
Authors: Shilpa A Patil; Wiam Bshara; Carl Morrison; E V Chandrasekaran; Khushi L Matta; Sriram Neelamegham Journal: Glycoconj J Date: 2014-10 Impact factor: 2.916
Authors: E V Chandrasekaran; Jun Xue; Jie Xia; Robert D Locke; Shilpa A Patil; Sriram Neelamegham; Khushi L Matta Journal: J Proteome Res Date: 2012-02-29 Impact factor: 4.466
Authors: Yin Gao; Rajindra P Aryal; Tongzhong Ju; Richard D Cummings; Gagandeep Gahlay; Donald L Jarvis; Khushi L Matta; Jason Z Vlahakis; Walter A Szarek; Inka Brockhausen Journal: Biochim Biophys Acta Date: 2013-04-08
Authors: Vincenzo Desiderio; Petros Papagerakis; Virginia Tirino; Li Zheng; Margarite Matossian; Mark E Prince; Francesca Paino; Luigi Mele; Federica Papaccio; Roberta Montella; Gianpaolo Papaccio; Silvana Papagerakis Journal: Oncotarget Date: 2015-01-01
Authors: Crina I A Balog; Kathrin Stavenhagen; Wesley L J Fung; Carolien A Koeleman; Liam A McDonnell; Aswin Verhoeven; Wilma E Mesker; Rob A E M Tollenaar; André M Deelder; Manfred Wuhrer Journal: Mol Cell Proteomics Date: 2012-05-09 Impact factor: 5.911
Authors: Stephanie Holst; Kathrin Stavenhagen; Crina I A Balog; Carolien A M Koeleman; Liam M McDonnell; Oleg A Mayboroda; Aswin Verhoeven; Wilma E Mesker; Rob A E M Tollenaar; André M Deelder; Manfred Wuhrer Journal: Mol Cell Proteomics Date: 2013-07-22 Impact factor: 5.911